文献リスト

1）日本妊娠高血圧学会．妊娠高血圧症候群（PIH）管理ガイドライン2009．東京: メジカルレビュー社; 2009

2）日本高血圧学会高血圧治療ガイドライン作成委員会．高血圧治療ガイドライン2009．東京: ライフサイエンス出版; 2014

3）Nelson DB, Ziadie MS, McIntire DD, et al. Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol. 2014; 210: 66. e1-7

4）Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online. 2006; 13: 680-6

5）van Veen TR, Panerai RB, Haeri S, et al. Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol. 2013; 122: 1064-9

6）Kaartokallio T, Klemetti MM, Timonen A, et al. Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia. Hypertension. 2014; 64: 172-7

7）Doridot L, Passet B, Méhats C, et al. Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension. 2013; 61: 662-8

8）van Rijn BB, Nijdam ME, Bruinse HW, et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol. 2013; 121: 1040-8

9）Macdonald-Wallis C, Tilling K, Fraser A, et al. Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2013; 209: 327. e1-17

10）Bogaerts A, Van den Bergh BR, Ameye L, et al. Interpregnancy weight change and risk for adverse perinatal outcome. Obstet Gynecol. 2013; 122: 999-1009

11）László KD, Liu XQ, Svensson T, et al. Psychosocial stress related to the loss of a close relative the year before or during pregnancy and risk of preeclampsia. Hypertension. 2013; 62: 183-9

12）Yu Y, Zhang S, Wang G, et al. The combined association of psychosocial stress and chronic hypertension with preeclampsia. Am J Obstet Gynecol. 2013; 209: 438. e1-12

13）Luo ZC, Julien P, Wei SQ, et al. Plasma cotinine indicates an increased risk of preeclampsia in previous and passive smokers. Am J Obstet Gynecol. 2014; 210: 232. e1-5

14）Pedersen M, Stayner L, Slama R, et al. Ambient air pollution and pregnancy-induced hypertensive disorders: a systematic review and meta-analysis. Hypertension. 2014; 64: 494-500

15）Scazzocchio E, Figueras F, Crispi F, et al. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Am J Obstet Gynecol. 2013; 208: 203. e1-10

16）Lupton SJ, Chiu CL, Hodgson LA, et al. Changes in retinal microvascular caliber precede the clinical onset of preeclampsia. Hypertension. 2013; 62: 899-904

17）Stergiotou I, Crispi F, Valenzuela-Alcaraz B, et al. Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol. 2013; 209: 558. e1-14

18）Martillotti G, Ditisheim A, Burnier M, et al. Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertension. 2013; 62: 802-8

19）Lam GK, Hopoate-Sitake M, Adair CD, et al. Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial. Am J Obstet Gynecol. 2013; 209: 119. e1-6

20）PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011; 377: 219-27

21）Craici IM, Wagner SJ, Bailey KR, et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension. 2013; 61: 1289-96

22）Macdonald-Wallis C, Tilling K, Fraser A, et al. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension. 2014; 64: 36-44

23）Leaños-Miranda A, Campos-Galicia I, Ramírez-Valenzuela KL, et al. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia. Hypertension. 2013; 61: 1118-25

24）Maynard SE, Crawford SL, Bathgate S, et al. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am J Obstet Gynecol. 2013; 209: 53. e1-9

25）Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013; 128: 2121-31

26）Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014; 63: 346-52

27）Wang K, Ahmad S, Cai M, et al. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation. 2013; 127: 2514-22

28）MIROS Study Group. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors, and preeclampsia. Am J Obstet Gynecol. 2013; 208: 390. e1-6

29）Major HD, Campbell RA, Silver RM, et al. Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia. Am J Obstet Gynecol. 2014; 210: 547. e1-7

30）Xia Y, Kellems RE. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ Res. 2013; 113: 78-87

31）Siddiqui AH, Irani RA, Zhang W, et al. Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension. 2013; 61: 472-9

32）Brewer J, Liu R, Lu Y, et al. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure re-sponse during pregnancy. Hypertension. 2013; 62: 886-92

33）Genest DS, Falcao S, Michel C, et al. Novel role of the renin-angiotensin system in preeclampsia superimposed on chronic hypertension and the effects of exercise in a mouse model. Hypertension. 2013; 62: 1055-61

34）Mirabito KM, Hilliard LM, Wei Z, et al. Role of inflammation and the angiotensin type 2 receptor in the regulation of arterial pressure during pregnancy in mice. Hypertension. 2014; 64: 626-31

35）Zhou J, Xiao D, Hu Y, et al, Mata-Greenwood E, Zhang L. Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats. Hypertension. 2013; 62: 599-607

36）Mazzuca MQ, Li W, Reslan OM, et al. Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy. Hypertension. 2014; 64: 632-43

37）Jobe SO, Ramadoss J, Wargin AJ, et al. Estradiol-17β and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites selectively stimulate production of prostacyclin in uterine artery endothelial cells: role of estrogen receptor-α versus estrogen receptor-β. Hypertension. 2013; 61: 509-18

38）Jobe SO, Tyler CT, Magness RR. Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction. Hypertension. 2013; 61: 480-7

39）Kiprono LV, Wallace K, Moseley J, et al. Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. Am J Obstet Gynecol. 2013; 209: 44. e1-6

40）Levron Y, Dviri M, Segol I, et al. The 'immunologic theory' of preeclampsia revisited: a lesson from donor oocyte gestations. Am J Obstet Gynecol. 2014; 211: 383. e1-5

41）McDonnold M, Dunn H, Hester A, et al. High risk human papillomavirus at entry to prenatal care and risk of preeclampsia. Am J Obstet Gynecol. 2014; 210: 138. e1-5

42）Rebelo F, Schlüssel MM, Vaz JS, et al. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status. J Hypertens. 2013; 31: 16-26

43）Burwick RM, Fichorova RN, Dawood HY, et al. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension. 2013; 62: 1040-5

44）Xu L, Lee M, Jeyabalan A, et al. The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am J Obstet Gynecol. 2014; 210: 149. e1-7

45）Chatterjee P, Kopriva SE, Chiasson VL, et al. Interleukin-4 deficiency induces mild preeclampsia in mice. J Hypertens. 2013; 31: 1414-23

46）Wang W, Parchim NF, Iriyama T, et al. Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia. Hypertension. 2014; 63: 595-606

47）Muñoz-Hernandez R, Miranda ML, Stiefel P, et al. Decreased level of cord blood circulating endothelial colony-forming cells in preeclampsia. Hypertension. 2014; 64: 165-71

48）Gammill HS, Aydelotte TM, Guthrie KA, et al. Cellular fetal microchimerism in preeclampsia. Hypertension. 2013; 62: 1062-7

49）Buurma AJ, Penning ME, Prins F, et al. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung. Hypertension. 2013; 62: 608-13

50）Henderson JT, Whitlock EP, O’Connor E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014; 160: 695-703

51）Bauer AJ, Banek CT, Needham K, et al. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension. 2013; 61: 1103-10

52）McDonnold M, Tamayo E, Kechichian T, et al. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol. 2014; 210: 542. e1-7

53）Nayeri UA, Buhimschi IA, Laky CA, et al. Antenatal corticosteroids impact the inflammatory rather than the antiangiogenic profile of women with preeclampsia. Hypertension. 2014; 63: 1285-92

54）White WM, Turner ST, Bailey KR, et al. Hypertension in pregnancy is associated with elevated homocysteine levels later in life. Am J Obstet Gynecol. 2013; 209: 454. e1-7

55）Sandvik MK, Leirgul E, Nygård O, et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol. 2013; 209: 569. e1-10

56）Visser S, Hermes W, Ket JC, et al. Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders. Am J Obstet Gynecol. 2014; 211: 373. e1-9

57）Hermes W, Franx A, van Pampus MG, et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol. 2013; 208: 474. e1-8

58）Männistö T, Mendola P, Vääräsmäki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013; 127: 681-90

59）Wu CC, Chen SH, Ho CH, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014; 210: 147. e1-8

60）Fraser A, Nelson SM, Macdonald-Wallis C, et al. Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension. 2013; 62: 614-20

61）Tuovinen S, Eriksson JG, Kajantie E, et al. Maternal hypertensive disorders in pregnancy and self-reported cognitive impairment of the offspring 70 years later: the Helsinki Birth Cohort Study. Am J Obstet Gynecol. 2013; 208: 200. e1-9

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp